Testosterone production by tumor tissue in partial androgen deficiency in aged men (PADAM)

Abstract

The aim of the study was examination of cause-effect relationships between PADAM, extragonadal production of androgens and high proliferative activity in aged men. The study group included 15 patients aged between 53 and 79 years with prostatic cancer (n = 5), urinary bladder cancer (n = 5) and cancer of the rectum (n = 5). Control samples of tissues of the prostatic gland, urinary bladder and rectum were obtained from dead bodies of men at the age between 18 and 29 years killed in the accidents at the age from 18 to 29 years. Testosterone levels in the tissues of peritumor zone of the prostate, in tumor tissue of patients with cancer of the prostate, urinary bladder and the rectum were higher than in blood serum. In prostatic cancer, testosterone in the tumor tissue was higher than in the tissues of prostatic peritumor zone. The values of Histochemical score AR of the peritumor zone in prostatic cancer patients were higher than those of the control group. It was detected that ER, PR, bcl-2, Ki-67 and p53 in prostatic tissue of young controls were absent while in patients with prostatic cancer these factors were expressed in the peritumor zone. In cancer of the urinary bladder, peritumor zone showed expression of PR, bcl-2, Ki-67 and p53, while no such expression was in the controls. ER, bcl-2, Ki-67 and p53 were registered in the peritumor zone of patients with cancer of the rectum but the controls had neither ER, bcl-2 norp53 while Ki-67 expression in rectal cancer was higher than in the controls. The results of the study suggest that testosterone production by some tumors and tissues of the peritumor zone accompanied with high proliferative activity and dysregulation of the cell cycle is secondary to PADAM. These changes arise to compensate testicular deficiency and are manifestations of metabolic syndrome (X-syndrome). In this situation immune system fails to utilize all atypical cells.

References

  1. Напалков Н. П. Общая онкология. Л.: Медицина; 1989. 9- 28.
  2. Gray A., Feldman N. A., McKinlay J. В., Longcope С. Age, disease, and changing sex-hormone levels in middle-aged men: Results of the Massachusetts male aging study. Clin. Endocrinol. 1991; 73(2): 1016-1025.
  3. Vermeulen A., Kaufman J. M. Androgens and cardiovascular disease in men and women. Aging Male 1998; 1: 35-50.
  4. Печерский А. В., Семиглазов В. Ф., Лоран О. Б. и др. Изменение уровня цитокинов у пациентов с раком предстательной железы после орхидэктомии. Terra Medica nova. 2003; 2: спец. вып. "Лаб. диагн.": 26-30.
  5. Лопаткин И. А. Руководство по урологии. М.: Медицина; 1998; т. 3: 374, 377-380, 385, 394-395, 504.
  6. Берштейн Л. М. Гормональный канцерогенез. СПб.: Наука; 2000. 10, 17, 24, 50-54, 65, 69, 129.
  7. Lavin N. Endocrinology. Moscow: Practica; 1999; 91-93, 102, 346, 369-409, 877-898.
  8. Лоран О. Б., Ceeaji А. С., Супряга О. М. Андриол в лечении секреторного бесплодия и климактерического синдрома у мужчин. Урол. и нефрол. 1999; 3: 41-44.
  9. Jonal W., Maas H., Stegner H. Е. Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples. Cancer Res. 1986; 46: 4296-4298.
  10. Glantz S. A. Primer of biostatistics. Moscow: Practica: 1999. 285-289.
  11. Kettyle W. M., Arky R. A. Endocrine pathophysiology. Moscow: Binom Publishers; 2001. 231-240.
  12. Берштейн Л. М. Внегонадная продукция эстрогенов (роль в физиологии и патологии). СПб.; Наука; 1998. 32-39, 48- 61, 69-99, 112-126.
  13. Burrows Н., Horning Е. Oestrogens and neoplasia. Springfield, Illinois: Charles С Thomas Publ.; 1952. 189.
  14. Зазеров В. Г., Северин Е. С. Молекулярные механизмы онкогенеза предстательной железы. Вестн. РАМН 1998; 5: 29-35.
  15. Панков А. Ю. Пролактин. В кн.: БМЭ. 3-е изд. М; 1983; т. 21: 134.
  16. Тареева И. Е. Нефрология. М.: Медицина; 1995; т. 1: 270- 303.
  17. Franklin R. В., Costello L. С. Prolactin directly stimulates citrate production and mitochondrial aspartate aminotransferase of prostate epithelial cells. Prostate 1990; 17: 13-18.
  18. Costello L. C., Franklin R. B. Effect of prolactin on the prostate. Prostate 1994; 24: 162-168.
  19. Ярилин А. А. Основы иммунологии. М.: Медицина; 1999. 51-71, 111-144.
  20. Roitt I., Brostoff J., Male D. Immunology. Moscow: Mir; 2000. 63-64, 168-193.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies